Cite
Striatal phosphodiesterase 10A availability is altered secondary to chronic changes in dopamine neurotransmission.
MLA
Ooms, Maarten, et al. “Striatal Phosphodiesterase 10A Availability Is Altered Secondary to Chronic Changes in Dopamine Neurotransmission.” EJNMMI Radiopharmacy & Chemistry, vol. 1, no. 1, Mar. 2016, pp. 1–17. EBSCOhost, https://doi.org/10.1186/s41181-016-0005-5.
APA
Ooms, M., Celen, S., De Hoogt, R., Lenaerts, I., Liebregts, J., Vanhoof, G., Langlois, X., Postnov, A., Koole, M., Verbruggen, A., Van Laere, K., & Bormans, G. (2016). Striatal phosphodiesterase 10A availability is altered secondary to chronic changes in dopamine neurotransmission. EJNMMI Radiopharmacy & Chemistry, 1(1), 1–17. https://doi.org/10.1186/s41181-016-0005-5
Chicago
Ooms, Maarten, Sofie Celen, Ronald De Hoogt, Ilse Lenaerts, Johnny Liebregts, Greet Vanhoof, Xavier Langlois, et al. 2016. “Striatal Phosphodiesterase 10A Availability Is Altered Secondary to Chronic Changes in Dopamine Neurotransmission.” EJNMMI Radiopharmacy & Chemistry 1 (1): 1–17. doi:10.1186/s41181-016-0005-5.